bupranolol has been researched along with isoproterenol in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (24.24) | 18.7374 |
| 1990's | 17 (51.52) | 18.2507 |
| 2000's | 8 (24.24) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillaume, JL; Méjean, A; Strosberg, AD | 1 |
| Borowski, E; Gross, G; Schümann, HJ | 1 |
| Champigny, O; Holloway, BR; Ricquier, D | 1 |
| Koike, H | 1 |
| Endoh, M; Takanashi, M | 2 |
| Hongo, K; Konishi, M; Kurihara, S; Okazaki, O; Suda, N | 1 |
| Kemken, J; Müller, BW; Ziegler, A | 1 |
| Endoh, M; Satoh, H | 1 |
| Blinks, JR; Endoh, M | 1 |
| Liu, GD; Yue, WL | 1 |
| Küppers, H; Palm, D; Pitschner, HF; Wellstein, A | 1 |
| Kaumann, AJ; Lemoine, H; Walter, M | 1 |
| Blinks, JR; Gilmour, DP; Kaumann, AJ; McInerny, TK | 1 |
| Kaumann, AJ; Lemoine, H; Münch, U; Wächter, W | 1 |
| Kaumann, AJ; Morris, TH; Sandrock, K | 1 |
| Horinouchi, T; Koike, K; Takayanagi, I | 1 |
| Berlan, M; Bousquet-Melou, A; Galitzky, J; Lafontan, M; Montastruc, JL | 1 |
| Berlan, M; Carpéné, C; Galitzky, J; Lafontan, M; Portillo, M; Reverte, M | 1 |
| Bar-Ilan, A; Geyer, O; Lazar, M; Nachman, R; Oron, Y | 1 |
| Ajisawa, Y; Akahane, M; Igawa, Y; Nishizawa, O; Takeda, H; Yamazaki, Y; Yoneyama, T | 1 |
| Gerhardt, CC; Gros, J; Issad, T; Strosberg, AD | 1 |
| Atgié, C; Berlan, M; Carpéné, C; Fontana, E; Galitzky, J; Lafontan, M | 1 |
| Horinouchi, T; Koike, K | 4 |
| Horinouchi, T; Koike, K; Tsujitani, M | 1 |
| Brawley, L; MacDonald, A; Shaw, AM | 1 |
| Endoh, M; Takahashi, R; Talukder, MA | 1 |
| Balligand, JL; Dessy, C; Ghisdal, P; Havaux, X; Moniotte, S; Noirhomme, P | 1 |
| Colledge, WH; Joseph, SS; Kaumann, AJ | 1 |
| Babu, RJ; Dhanasekaran, M; Pandit, JK; Singh, PN; Vaithiyalingam, SR | 1 |
33 other study(ies) available for bupranolol and isoproterenol
| Article | Year |
|---|---|
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dithiothreitol; Lipolysis; Propanolamines; Receptors, Adrenergic, beta | 1995 |
Changes of adrenoceptor-mediated responses in the pithed rat during propylthiouracil-induced hypothyroidism.
Topics: Animals; Atropine; Blood Pressure; Bupranolol; Clonidine; Disease Models, Animal; Electric Stimulation; Heart Rate; Hypothyroidism; Isoproterenol; Male; Norepinephrine; Phenylephrine; Propylthiouracil; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Spinal Cord; Tubocurarine | 1979 |
Regulation of UCP gene expression in brown adipocytes differentiated in primary culture. Effects of a new beta-adrenoceptor agonist.
Topics: Adipose Tissue, Brown; Adrenergic beta-Agonists; Animals; Bupranolol; Carrier Proteins; Cell Differentiation; Cells, Cultured; Gene Expression; Ion Channels; Isoproterenol; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mitochondrial Proteins; Phenoxyacetates; Propranolol; Rats; RNA, Messenger; Uncoupling Protein 1 | 1992 |
[Effect of halothane on the mechanical properties of rabbit right ventricular papillary muscle in the presence of either alpha or beta stimulant positive inotropic agent].
Topics: Animals; Bupranolol; Halothane; Isoproterenol; Muscles; Phenylephrine; Rabbits | 1992 |
Characterization of positive inotropic effect of endothelin on mammalian ventricular myocardium.
Topics: Animals; Bupranolol; Cardiotonic Agents; Dogs; Endothelins; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Isoproterenol; Kinetics; Male; Myocardial Contraction; Papillary Muscles; Phenylephrine; Phorbol 12,13-Dibutyrate; Rabbits; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Cell Surface; Receptors, Endothelin | 1991 |
Modulation of Ca2+ transients and contractile properties by beta-adrenoceptor stimulation in ferret ventricular muscles.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Animals; Bupranolol; Calcium; Ferrets; In Vitro Techniques; Isoproterenol; Kinetics; Myocardial Contraction; Papillary Muscles; Receptors, Adrenergic, beta; Ryanodine | 1990 |
Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of microemulsions and matrix patches as vehicle.
Topics: Administration, Cutaneous; Animals; Bupranolol; Emulsions; Heart Rate; Isoproterenol; Pharmaceutical Vehicles; Rabbits; Timolol | 1991 |
Inotropic effects of endothelin on mammalian ventricular contractility.
Topics: Animals; Bupranolol; Dogs; Endothelins; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Phenylephrine; Phorbol 12,13-Dibutyrate; Prazosin; Rabbits; Rats; Rats, Inbred Strains; Ventricular Function | 1991 |
Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Topics: Amrinone; Animals; Bupranolol; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Female; Heart; Heart Ventricles; Imidazoles; In Vitro Techniques; Isometric Contraction; Isoproterenol; Male; Muscle Relaxation; Myocardial Contraction; Myocardium; Pyridones | 1990 |
Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors.
Topics: Animals; Bupranolol; Calcium; Epinephrine; Female; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Isoproterenol; Luminescent Measurements; Male; Myocardial Contraction; Myofibrils; Phenylephrine; Rabbits; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sympathomimetics | 1988 |
[The effect of beta-receptor blockers on the isoprenaline-induced increase of heart muscle oxygen consumption].
Topics: Adrenergic beta-Antagonists; Animals; Bupranolol; Fluorobenzenes; Isoproterenol; Myocardium; Oxygen Consumption; Propanolamines; Swine | 1985 |
Transdermal delivery of bupranolol: pharmacodynamics and beta-adrenoceptor occupancy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Blood Proteins; Bupranolol; Exercise Test; Heart Rate; Humans; In Vitro Techniques; Isoproterenol; Kinetics; Male; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta | 1986 |
Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.
Topics: Animals; Bupranolol; Cimetidine; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Kinetics; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Receptors, Adrenergic, beta; Serotonin Antagonists; Sinoatrial Node; Stereoisomerism; Trachea | 1984 |
Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol.
Topics: Adrenergic beta-Antagonists; Animals; Bupranolol; Cats; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Sotalol; Time Factors | 1980 |
Evidence that (+)-bupranolol interacts directly with myocardial beta-adrenoceptors. Control of optical purity with differential thermal analysis.
Topics: Animals; Bupranolol; Calorimetry, Differential Scanning; Cats; Female; Humans; Isoproterenol; Myocardium; Optical Rotatory Dispersion; Propanolamines; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Temperature | 1980 |
3H-(-)-Bupranolol, a new beta-adrenoceptor radioligand: characterization of its binding to kitten heart beta-adrenoceptors.
Topics: Adenylyl Cyclases; Animals; Bupranolol; Cats; In Vitro Techniques; Isoproterenol; Kinetics; Membranes; Myocardium; Propanolamines; Protein Binding; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stereoisomerism | 1981 |
Possible mechanisms of beta-adrenoceptor-mediated relaxation induced by noradrenaline in guinea pig taenia caecum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Cecum; Cyclic AMP; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Proteins; Muscle Relaxation; Muscle, Smooth; Norepinephrine; Propranolol; Receptors, Adrenergic, beta | 1995 |
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bupranolol; Dioxoles; Dogs; Ethanolamines; Heart Rate; Isoproterenol; Male; Nitroprusside; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow; Skin | 1994 |
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Cell Membrane; Dogs; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Isoproterenol; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1993 |
Beta3-adrenergic relaxation of bovine iris sphincter.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Bupranolol; Cattle; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Ethanolamines; Iris; Isoproterenol; Muscle Relaxation; Muscle, Smooth; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3 | 1998 |
Possible beta 3-adrenoceptor-mediated relaxation of the human detrusor.
Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Adult; Aged; Bupranolol; Dobutamine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth; Phentolamine; Procaterol; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Urinary Bladder | 1998 |
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Colforsin; Cricetinae; Dioxoles; Enzyme Activation; Epinephrine; Ethanolamines; Humans; Insulin; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; Phentolamine; Prazosin; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Signal Transduction; Yohimbine | 1999 |
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adult; Animals; Binding, Competitive; Biogenic Amines; Bupranolol; CHO Cells; Cricetinae; Dioxoles; Dogs; Ethanolamines; Female; Gene Expression; Guinea Pigs; Humans; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lipolysis; Male; Mammals; Mesocricetus; Norepinephrine; Octopamine; Oxygen Consumption; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Species Specificity | 1999 |
Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bupranolol; Butoxamine; Catecholamines; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-3 | 1999 |
[Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastrointestinal tissue systems].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Digestive System; Duodenum; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; Ileum; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta | 1999 |
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Bupranolol; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Pindolol; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Substrate Specificity; Vasodilator Agents | 2000 |
Inotropic effects of OR-1896, an active metabolite of levosimendan, on canine ventricular myocardium.
Topics: Acetamides; Animals; Bupranolol; Calcium; Cardiotonic Agents; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Female; Hydrazones; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Pyridazines; Simendan | 2000 |
Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 2000 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Further evidence that (+/-)-carteolol-induced relaxation is mediated by beta2-adrenoceptors but not by beta3-adrenoceptors in the guinea pig taenia caecum.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Cecum; Guinea Pigs; In Vitro Techniques; Isoproterenol; Kinetics; Male; Muscle Relaxation; Muscle, Smooth; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Stereoisomerism | 2000 |
Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Apamin; Arterioles; Bupranolol; Charybdotoxin; Child; Coronary Vessels; Endothelium, Vascular; Ethanolamines; Female; Humans; Isoproterenol; Male; Membrane Potentials; Microcirculation; Microscopy, Video; Middle Aged; Nadolol; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; RNA, Messenger; Vasodilation | 2004 |
Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the beta1-adrenoceptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aspartic Acid; Binding Sites; Bupranolol; CHO Cells; Cricetinae; Cricetulus; Drug Interactions; Isoproterenol; Ligands; Propanolamines; Receptors, Adrenergic, beta-1 | 2004 |
Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Animals; Area Under Curve; beta-Cyclodextrins; Bupranolol; Drug Antagonism; Drug Delivery Systems; Female; Heart Rate; Injections, Intravenous; Isoproterenol; Male; Permeability; Pyrrolidinones; Rabbits; Skin; Skin Absorption; Tachycardia | 2008 |